Published 2 hours ago • loading... • Updated 2 hours ago

Daily Dose: Measles status in question, new GLP-1 eye warning, hope for stiff person syndrome and more

Summary by WFAA 8abc

Here are the top health headlines for Tuesday, Nov. 10, 2026.

4 Articles

KTVB

+3 Reposted by 3 other sources

Center

Daily Dose: Measles status in question, new GLP-1 eye warning, hope for stiff person syndrome and more

Here are the top health headlines for Tuesday, Nov. 10, 2026.

2 hours ago·Boise, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources4

Leaning Left1Leaning Right0Center3Last Updated1 hour agoBias Distribution

75% Center

Bias Distribution

75% of the sources are Center

75% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

WFAA 8abc broke the news in Dallas, United States 2 hours ago on Tuesday, November 10, 2026.

Sources are mostly out of (0)

Daily Dose: Measles status in question, new GLP-1 eye warning, hope for stiff person syndrome and more

4 Articles

4 Articles

Daily Dose: Measles status in question, new GLP-1 eye warning, hope for stiff person syndrome and more

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

Anvisa Records Two New Semiglutide Slimming Pens - Tribuna Do Norte

Conexeu Sciences Launches Human Collagen Initiative for Regenerative Aesthetics as GLP-1 Drives Demand for Tissue Restoration

FDA adds rare vision-loss warning to popular GLP-1 drugs

These Weight Loss Medicines and Diabetes Should Warn of Serious Damage to Vision

Animal study raises questions about semaglutide safety during pregnancy

Type 2 Diabetes Patients 'May Risk Heart Issues if They Stop Weight-Loss Jabs'

Similar News Topics

Similar News Topics

More stories like this

Anvisa Records Two New Semiglutide Slimming Pens - Tribuna Do Norte

Conexeu Sciences Launches Human Collagen Initiative for Regenerative Aesthetics as GLP-1 Drives Demand for Tissue Restoration

FDA adds rare vision-loss warning to popular GLP-1 drugs

These Weight Loss Medicines and Diabetes Should Warn of Serious Damage to Vision

Animal study raises questions about semaglutide safety during pregnancy

Type 2 Diabetes Patients 'May Risk Heart Issues if They Stop Weight-Loss Jabs'

Daily Dose: Measles status in question, new GLP-1 eye warning, hope for stiff person syndrome and more

4 Articles

4 Articles

Daily Dose: Measles status in question, new GLP-1 eye warning, hope for stiff person syndrome and more

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

Anvisa Records Two New Semiglutide Slimming Pens - Tribuna Do Norte

Conexeu Sciences Launches Human Collagen Initiative for Regenerative Aesthetics as GLP-1 Drives Demand for Tissue Restoration

FDA adds rare vision-loss warning to popular GLP-1 drugs

These Weight Loss Medicines and Diabetes Should Warn of Serious Damage to Vision

Animal study raises questions about semaglutide safety during pregnancy

Type 2 Diabetes Patients 'May Risk Heart Issues if They Stop Weight-Loss Jabs'

Similar News Topics

Similar News Topics

More stories like this

Anvisa Records Two New Semiglutide Slimming Pens - Tribuna Do Norte

Conexeu Sciences Launches Human Collagen Initiative for Regenerative Aesthetics as GLP-1 Drives Demand for Tissue Restoration

FDA adds rare vision-loss warning to popular GLP-1 drugs

These Weight Loss Medicines and Diabetes Should Warn of Serious Damage to Vision

Animal study raises questions about semaglutide safety during pregnancy

Type 2 Diabetes Patients 'May Risk Heart Issues if They Stop Weight-Loss Jabs'

Bias Distribution

Factuality